ArticleThe Journal of clinical and aesthetic dermatology2025
Nonmelanoma Skin Cancer in South Florida: A Change in the Relative Incidence of Basal and Squamous Cell Carcinoma.
Article in The Journal of clinical and aesthetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety and Efficacy of Aminolevulinic Acid Hydrochloride Topical Gel, 10%, with Red Light in the Treatment of Facial Cutaneous Squamous Cell Carcinoma In Situ.The Journal of clinical and aesthetic dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveUltraviolet (UV) radiation is a major cause of nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Due to its demographics and geographic location, Florida's population is at increased risk of NMSC. While historical epidemiology suggests BCC has a significantly greater incidence than SCC, a 2012 study in South Florida reported a reverse in this ratio, with significantly higher SCC rates, warranting further investigation.
methodsA South Florida dermatology database was analyzed for confirmed NMSC biopsy results from 2024. Lesions were categorized into BCC (superficial and nonsuperficial subtypes) and SCC (in situ SCC [isSCC] and invasive subtypes).
resultsAmong 856 NMSC lesions, 247 (28.9%) were BCC and 609 (71.1%) were SCC. Subtypes included 54 superficial BCC (6.3%), 193 nonsuperficial BCC (22.5%), 268 isSCC (31.3%), and 341 invasive SCC (39.8%). DISCUSSION: These results align with earlier findings, contradicting the belief that BCC is the most common NMSC. SCC subtypes represented more than 70% of cases, suggesting a shift in incidence patterns. This trend may be linked to the early use of UV-B protection-dominant sunscreens, which offer less protection against UV-A, a significant factor in the development of SCC. Additionally, treating SCC-suspicious lesions as actinic keratoses in favor of biopsy for BCC-suspicious lesions may have contributed to prior findings.
conclusionOur findings challenge traditional epidemiologic teachings, showing a higher incidence of SCC than BCC. These trends may reflect historical photoprotection and/or changing biopsy practices.
Indexed as
Identifiers
41446721PMC12724980What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.